Johannes Breyer

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

Richard Sylvester, Óscar Rodríguez, Virginia Hernández et al. · European Urology · 2021 · 463 citations

Medicine, Oncology, Urology +10

The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer Subtypes

Carolin Pfannstiel, Pamela L. Strissel, Katherine B. Chiappinelli et al. · Cancer Immunology Research · 2019 · 232 citations

Medicine, Oncology, Urology +17

Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab

Markus Eckstein, Philipp Erben, Maximilian C. Kriegmair et al. · European Journal of Cancer · 2018 · 103 citations

Medicine, Oncology, Pharmacology +16

Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non–muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non–muscle-invasive Bladder Cancer Guidelines Panel Study

Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl et al. · European Urology Oncology · 2021 · 101 citations

Medicine, Oncology, Urology +12

In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival

Johannes Breyer, Ralph M. Wirtz, Wolfgang Otto et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2017 · 67 citations

Medicine, Oncology, Urology +16